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Known risk factors for various cancer forms can only partly
explain the incidence of cancer in adult populations. There is
general agreement that non-genetic factors occurring in adult life,
including exposure to smoke or pollutants, dietary factors, occupa-
tional exposure and viral infections, are the predominant contribu-
tors to cancer causation. Only about 5–10% of all cancer can be
attributed to dominant genes or inherited cancer syndromes
(Lynch et al, 1997). The prenatal or in utero environment has only
recently been examined for its role in cancer in adults (Ekbom,
1998). 
During the past decade, it has been observed that several
chronic diseases in adulthood may be a consequence of influences
occurring during the period of gestational development (Joseph
and Kramer, 1996). Size at birth, an indicator of conditions during
fetal development, may be an important factor in cancer pathogen-
esis. Previous studies relating size at birth to adult cancer have
focused on, what may be termed, hormone-related cancers, that is,
breast, uterine, ovarian, prostate and testicular cancer (Brown et al,
1986; Ekbom et al, 1992, 1996, 1997; Michels et al, 1996;
Sanderson et al, 1996; Tibblin et al, 1995). The relation between
size at birth and other adult cancers has not been reported in the
literature, while among children, high birth weight has been asso-
ciated with certain cancers including neuroblastoma, Wilms’
tumour, leukaemia and brain tumours (Daling et al, 1984; Yeazel
et al, 1997). 
The relation between size at birth, as indicated by birth weight
and birth length, and cancer risk was assessed in a population
study of adult Swedish women. 
METHODS 
The present investigation is based on a prospective study initiated
in 1968 of 4 birth cohorts of altogether 1260 women born on
selected dates in the years 1914, 1918, 1922 and 1930 residing in
Göteborg at the study start (Bengtsson et al, 1973). We comple-
mented the original population study material by tracing all
females born in Göteborg on the same dates who had survived to at
least 15 years of age but who had moved out of the area before the
study onset in 1968 and/or had died before 1968 (n 479). The
women included in the study were of singleton birth, born in
Sweden (n 1739). 
Original midwife records for both home and hospital deliveries
were traced in city and regional archives in Sweden. Measures of
birth weight, birth length and other birth factors were available
dependent on year of birth and delivery site (Andersson et al,
2000b). Demographic variables and maternal characteristics were
derived from midwife records (gestational age, maternal protein-
uria, maternal age, birth order), parish records (maternal age, birth
order, own parity), and by questionnaire prior to health examina-
tions in 1968 and 1974 (prospective population study) or sent home
in 1995 (complementary population) to attain information on age at
menarche and own parity. The questionnaire was reviewed at each
health examination with a study nurse or by telephone interview
(complementary population) to assure completeness of data collec-
tion. Missing data on age at menarche is mainly for the comple-
mentary population who were deceased before 1995. 
At the time of the study, the Swedish National Cancer Register
was complete up to 1997 and the Regional Cancer Register for
western Sweden through 1998. Since 1958, the attending physician
must report all newly diagnosed cases of cancer to one of 6 regional
cancer registries covering the whole country, and a separate report is
required from the pathologist or cytologist (Socialstyrelsen, 1997).
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These reports are compiled at both the regional and national level.
By means of the unique 10-digit personal number assigned to all
residents of Sweden, the population study database could be
matched with the cancer registries to identify primary incident
cases. Date of death (from any cause) was determined by matching
personal identification numbers with the Swedish Cause of Death
Registry and by confirmation with parish records. 
Cancer cases were analysed as combined all site cancer
morbidity and also divided into ‘hormone-related’ and ‘non-
hormonal’ cancers and are referred to as such in the following
analysis and discussion; the former comprises cancers of the
breast, uterus and ovaries, the major cancer sites with a hormonal
aetiology (Miller, 1978). Non-hormonal cancers, as defined here,
are thus all other cancer sites. As there is evidence that cancer of
the colon may be hormone-related (Potter, 1995), the defined
hormone-related sites and colon cancer are also examined in
combination. Cancers of the ‘digestive system’, ICD7 codes
150–158, are analysed separately to examine a sub-group of the
‘non-hormone-related’ cancers. 
This study was approved by the Research Ethics Committee of
Göteborg University. 
Statistical methods 
Characteristics of participants and non-participants were
compared using a 2-sample t-test for continuous variables and chi-
squared test for proportions for factors which may influence
cancer risk or birth outcome – maternal age, birth order of the
participant, own parity (defined as number of pregnancies) and age
of menarche of the participants. Birth weight and birth length were
analysed as continuous variables and in population quintiles birth
weight and tertiles birth length. Cox proportional hazards model-
ling was used to examine trend in cancer risk in relation to size at
birth, treating weight and length separately, and in modelling
cancer risk with consideration of covariates implicated in cancer
pathogenesis: maternal proteinuria, birth order, own parity and age
at menarche. All analyses were adjusted for gestational age as well
as cohort membership to adjust for cohort effects. All individuals
were included in the Cox models up to time of first cancer diag-
nosis, death from any cause or the cessation of the study. The
validity of the proportional hazards assumption was tested and no
significant effects for time dependence were found. All analyses
were carried out using the SAS software release 6.12 statistical
package 1989–1996 and specifically the PHREG procedure. 
RESULTS 
Of the 1739 women eligible for inclusion in the study, midwife
records (home and hospital deliveries) for the births of 1184 (68%)
of the women were identified in which birth weight was recorded.
Of these records, 1105 contained useable information on gesta-
tional age. Another 25 women were removed from further analysis
as they were not alive in January 1958 when the National Cancer
Register was initiated. A total of 1080 women were thus included
in the present study. This represents participation by 53.4% (born
1914), 50.4% (1918), 64.2% (1922), and 77.8% (1930) of the orig-
inal birth cohorts. In total 76.7% (827/1080) of the participants
were born in Göteborg. 
There was no statistically significant difference in age at
menarche or own parity in women without known birth weight or
gestational age from midwife records and those included in the
study. Women included in the study had slightly younger mothers
(P < 0.05) (Table 1a) and were subsequently of lower birth order
(P < 0.001) (Table 1b). Ages ranged from 28 (1930 cohort, age in
1958) to 84 years (1914 cohort, age in 1998). Mean, standard devi-
ation and range of birth weight per quintile and birth length per
tertile are shown in Table 2. 
In total, 262 primary cancer cases (24.3% of the 1080 women)
were identified from the matching of our database with that of the
Swedish National Cancer Registry (1958–1997) and the Regional
Cancer Registry (1958–1998) (Table 3). The distribution of cancer
cases per birth weight quintile and birth length tertile is presented
in Table 2. 
Birth weight and cancer risk 
Univariate analysis 
A significant and positive trend was found between birth weight,
as a continuous variable, and all cancers (P = 0.006) and non-
hormonal cancers (P = 0.003). A positive trend was also found
between birth weight and combined hormone-related cancers,
breast cancer alone, cancers of the digestive system and for
hormone-related cancer together with colon cancer, but these
relations were not statistically significant. 
Modelling cancer risk and birth weight 
Cancer risk (all sites combined) was significantly higher in the 3
highest birth weight quintiles in relation to the lowest quintile of
birth weight, an increase in risk by 54–71% adjusted for gestational
age (Table 4). When separately analysing combined hormone-
related cancers or breast cancer alone and accounting for gesta-
tional age, a positive but statistically non-significant association
was observed between birth weight and cancer risk. However,
when only the non-hormonal cancers were included in the analysis,
the statistically significant positive relation to birth weight
remained. A 2-fold increase in cancer risk was found in the highest
quintile of birth weight with reference to the lowest quintile (Table
4), (RR 2.07, 95% CL 1.22, 3.50, adjusted for gestational age). The
subgroup of digestive cancer found a more than 2-fold risk for
cancer in the highest birth weight quintile compared to the lowest,
however not statistically significant. A similar trend was found for
hormone-related cancer sites together with colon cancer. 
Addition of covariates to the models did not have a marked
effect on the relation between birth weight and cancer risk (Table
4). Although not statistically significant, slightly different effects
are seen dependent on whether hormonal or non-hormonal cancers
are included in the analysis. For hormone-related cancers, birth
order and age at menarche had the most influence on this relation,
while maternal proteinuria, birth order and own parity had the
most effect on non-hormonal cancer risk. 
Birth length and cancer risk 
Univariate analysis 
A positive and statistically significant trend was found between
birth length and all cancers combined (P = 0.007), and non-
hormonal cancers (P = 0.011), while a marginally significant trend
was found for combined hormone-related cancers and colon
cancer (P = 0.058), adjusted for gestational age. 
Modelling cancer risk and birth length 
The incidence of all site cancer was statistically significantly
higher in the highest tertile of birth length in reference to theCancer risk relation to birthweight 1195
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lowest tertile (Table 5), an increase of about 60% adjusted for
gestational age. For hormone-related cancer sites combined and
breast cancer alone, respectively, cancer risk increased by 35% and
48% in the highest tertile birth length in reference to the lowest,
however not statistically significant. Analysis of non-hormonal
cancer revealed a significant positive relation between birth length
and cancer risk. This reflects a 72% increase in risk in the highest
tertile in relation to the lowest tertile birth length (RR 1.72,
95% CL 1.12, 2.66 adjusted for gestational age). There was no
significant increase in risk for digestive cancer across birth length
tertiles. The combination of hormone-related cancer and colon
cancer resulted in a raised cancer risk in tertile III compared to
tertile I, however not statistically significant (RR 1.57, 95% CL
0.96, 2.56). The addition of covariates in the Cox models did not
have any marked effect on the relations with all cancer sites
combined (Table 5). However, analysis of the subdivisions of
cancer sites revealed a different picture with respect to the
covariate age at menarche. Inclusion of age at menarche in the
models resulted in a 62% increase in hormone-related cancer risk
in the highest birth length tertile compared to the lowest tertile,
Table 1a Study population characteristics 
Participantsa Women excludedb
No. Mean (SD) Range No. Mean (SD) Range 
Demographic characteristics 
Maternal age (y)c 1080 29.2 (6.3) 16.3–48.0 650 30.3 (6.5) 16.5–47.7 
Age at menarche (y) 912 13.8 (1.4) 10–20 579 13.8 (1.3) 10–20 
aWomen with original midwife records and known gestational age. bWomen without traced midwife records or
with missing gestational age. ct-test for heterogeneity, P < 0.05. 
Table 1b Study population characteristics 
Participantsa Women excludedb
No. % No. % 
Demographic characteristics 
Birth orderc d
1 419 38.8 157 28.8 
2–3 406 37.5 193 35.4 
³4 255 23.7 196 35.8 
Paritye
0 177 16.4 132 20.2 
1–2 542 50.3 314 48.1 
³3 357 33.2 207 31.7 
aWomen with original midwife records and known gestational age. bWomen without
traced midwife records or with missing gestational age. cMissing for 113 women excluded
from study. dchi-squared test for heterogeneity, P < 0.001. eMissing for 4 participants and
6 excluded women. 
Table 2 Birth weight, birth length and cancer cases (no.) by cancer site per birth weight quintile (Q) and birth length tertile (T) 
Birth weight (g) Cancer site (no. of cases) 
No. Mean SD Range All site  Hormonal Breast Non- Digestive  Hormonal +
hormonal colon
Q1 217 2745 277 1600–3000 39 17 9 22 6 21 
Q2 207 3204 92 3010–3349 45 18 10 27 9 23 
Q3 206 3475 62 3350–3590 54 25 14 29 5 27 
Q4 217 3738 99 3600–3960 57 21 14 36 9 24 
Q5 233 4241 285 4000–5500 67 23 15 44 14 32 
All 1080 3495 547 1600–5500 262 104 62 158 43 127 
Birth length (cm) 
T1 292 47.6 2.1 35–49 55 22 11 33 11 27 
T2 226 50.0 0.2 49.5–50.5 44 17 12 27 6 19 
T3 354 52.4 1.7 51–60 99 35 20 64 19 47 
All 872 50.2 2.6 35–60 198 272 43 124 36 93 
SD, standard deviation. although not statistically significant (RR 1.62 95% CL 0.86, 3.06,
P for trend = 0.12). For breast cancer risk there was a 2-fold
increase in risk in the highest length tertile compared to the lowest
(RR 2.21 95% CL 0.88, 5.53, P for trend = 0.09). With hormonal
and colon cancers combined, inclusion of age at menarche resulted
in a significantly increased cancer risk in the highest birth length
tertile (RR 1.80 95% CL 1.02, 3.17). Inclusion of age at menarche
in non-hormonal and digestive cancer models resulted in a slight
decrease in cancer risk for these cancer forms. 
DISCUSSION 
High weight or length at birth was associated with a significant
increase in risk for cancer in adulthood. To look at more specific
divisions of cancer sites, analyses were carried out at the level of
non-hormonal and hormonal-associated cancer sites. Non-
hormonal cancer sites combined (all sites other than the breast,
uterus or ovary) showed a linear and statistically significant
increase in cancer risk from the lowest to highest birth weight
quintile and birth length tertile, a relation not previously reported.
The different association patterns for non-hormonal and
hormonal-associated cancers suggest that several factors may be
involved in the relationship, working in different directions, of
possibly varying importance and mechanistic expression depen-
dent on cancer site. 
In 1990 a role for size at birth in breast cancer morbidity was
hypothesized (Trichopoulos, 1990). Indications were reported of a
positive (though not significant) relationship between weight at
birth and breast cancer (Ekbom et al, 1992, 1997) as was also
found in a recent British cohort (Stavola et al, 2000) and in the
current study. An increased risk for prostate cancer has been found
with high birth weights (Ekbom et al, 1996; Tibblin et al, 1995),
1196 SW Andersson et al 
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Table 3 Frequency of cancer diagnosis in 1080 Swedish women 
Cancer site ICD-7 No. of cases 
Hormone related 
Breast 170 62 
Female reproductive organs 172–176 42 
Non-hormone related 
Ear, nose & throat 140–148, 160, 161 5 
Digestive system (total) 150–158 43 
Colon (alone) (153, 154) (23) 
Lung 162, 163 19 
Urinary system 180–181 9 
Malignant melanoma 190 6 
Nervous system 193 14 
Endocrine system 194, 195 10 
Leukaemia & lymphoma 200–209 23
Others 164, 171, 191–192,196–199 29 
Total cases 262 
Table 4 Cancer risk by quintilea birth weight, singleton births, with known gestational age (n = 1080 women) 
Rate ratio (95% confidence limits) 
Q2 Q3 Q4 Q5 P for trend 
All sitesb (Cases = 262) 1.27 (0.82, 1.96)  1.54 (1.01, 2.33) 1.61 (1.06, 2.44) 1.71 (1.14, 2.56) 0.0054 
c + maternal proteinuria 1.38 (0.88, 2.16)  1.57 (1.02, 2.42) 1.68 (1.09, 2.60) 1.77 (1.16, 2.70) 0.0064 
+birth order 1.26 (0.82, 1.94) 1.50 (0.98, 2.28) 1.56 (1.02, 2.37) 1.60 (1.05, 2.43) 0.0189 
+own parity 1.29 (0.83, 1.99) 1.57 (1.03, 2.39) 1.63 (1.07, 2.49) 1.74 (1.16, 2.62) 0.0046 
+age at menarched 1.39 (0.86, 2.23) 1.37 (0.85, 2.22) 1.53 (0.95, 2.45) 1.66 (1.05, 2.63) 0.0343 
Hormonalb,e (Cases = 104) 1.12 (0.56, 2.19)  1.56 (0.84, 2.92) 1.29 (0.67, 2.49) 1.28 (0.67, 2.42) 0.427 
c + maternal proteinuria 1.13 (0.57, 2.25)  1.51 (0.79, 2.88) 1.28 (0.65, 2.51) 1.30 (0.67, 2.51) 0.431 
+birth order 1.12 (0.57, 2.19) 1.55 (0.83, 2.91) 1.28 (0.66, 2.48) 1.25 (0.65, 2.42) 0.479 
+own parity 1.09 (0.56, 2.13) 1.54 (0.82, 2.87) 1.25 (0.65, 2.41) 1.27 (0.67, 2.41) 0.430 
+age at menarched 1.06 (0.50, 2.22) 1.17 (0.56, 2.43) 1.21 (0.58, 2.49) 1.38 (0.69, 2.76) 0.325 
Breastb (Cases = 62) 1.16 (0.47, 2.87)  1.65 (0.71, 3.86) 1.58 (0.67, 3.72) 1.57 (0.67, 3.64) 0.228 
c+maternal proteinuria 1.18 (0.45, 3.07)  1.69 (0.69, 4.12) 1.73 (0.71, 4.22) 1.63 (0.67, 3.97) 0.198 
+birth order 1.14 (0.46, 2.84) 1.59 (0.68, 3.73) 1.51 (0.64, 3.58) 1.43 (0.60, 3.41) 0.348 
+own parity 1.14 (0.46, 2.83) 1.64 (0.70, 3.82) 1.56 (0.66, 3.68) 1.57 (0.68, 3.66) 0.223 
+age at menarched 1.13 (0.39, 3.29) 1.53 (0.56, 4.21) 1.76 (0.66, 4.69) 1.93 (0.75, 5.00)  0.105 
Non-hormonalb,f (Cases = 158) 1.39 (0.78, 2.46) 1.50 (0.85, 2.63) 1.87 (1.08, 3.22) 2.07 (1.22, 3.50) 0.0033 
c+maternal proteinuria 1.59 (0.89, 2.87)  1.61 (0.90, 2.90) 2.03 (1.15, 3.59) 2.19 (1.26, 3.80) 0.0042 
+birth order 1.37 (0.77, 2.43) 1.44 (0.82, 2.54) 1.78 (1.03, 3.08) 1.88 (1.09, 3.23) 0.0143 
+own parity 1.45 (0.81, 2.59) 1.58 (0.89, 2.79) 1.95 (1.12, 3.40) 2.14 (1.25, 3.66) 0.0028 
+age at menarched 1.68 (0.90, 3.14) 1.53 (0.80, 2.91) 1.81 (0.97, 3.38) 1.92 (1.04, 3.55) 0.0042 
Digestive systemb (Cases = 43) 1.73 (0.60, 4.94) 0.97 (0.29, 3.23) 1.74 (0.60, 5.04)  2.47 (0.92, 6.62) 0.0829 
c + maternal proteinuria 2.07 (0.68, 6.29)  1.04 (0.30, 3.66) 1.82 (0.59, 5.62) 2.22 (0.76, 6.50) 0.2214 
+ birth order 1.68 (0.59, 4.81) 0.89 (0.27, 2.97) 1.56 (0.53, 4.54) 1.97 (0.71, 5.47) 0.2379 
+ own parity 1.70 (0.59, 4.86) 0.96 (0.29, 3.20) 1.71 (0.59, 4.96) 2.48 (0.93, 6.66) 0.0792 
+ age at menarched 1.57 (0.53, 4.67) 0.63 (0.15, 2.56) 1.19 (0.37, 3.84) 1.52 (0.51, 4.58)  0.6558 
Hormonal + colonb (Cases = 127) 1.20 (0.66, 2.19) 1.42 (0.79, 2.53) 1.25 (0.69, 2.28)  1.51 (0.86, 2.67) 0.182 
c + maternal proteinuria 1.26 (0.68, 2.35)  1.40 (0.76, 2.56) 1.25 (0.67, 2.34) 1.51 (0.84, 2.73) 0.227 
+ birth order 1.20 (0.66, 2.19) 1.42 (0.79, 2.53) 1.25 (0.68, 2.28) 1.50 (0.84, 2.68) 0.208 
+ own parity 1.17 (0.64, 2.14) 1.41 (0.79, 2.51) 1.22 (0.67, 2.23) 1.51 (0.86, 2.66) 0.177 
+ age at menarched 1.11 (0.57, 2.14) 1.03 (0.52, 2.02) 1.18 (0.61, 2.27) 1.37 (0.74, 2.57)  0.318 
a Where quintile 1 (Q1) is reference. bAdjusted for cohort membership and gestational age. cFurther adjusted for listed factor. dAge at menarche available for
only 912 women. eWhere hormonal = breast, uterine and ovarian cancers and fnon-hormonal = all other sites. Cancer risk relation to birthweight 1197
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while low birth weight has been associated with testicular cancer
in young adults (Brown et al, 1986). 
Birth order, pregnancy, toxaemia, age at menarche and preg-
nancy history may be risk factors for cancer (Janerich et al, 1989;
Hsieh et al, 1990; Potischman and Troisi, 1999). We therefore
examined the effect of including these factors in the statistical
modelling but found no marked effect on the relation between
weight or length at birth and cancer in adulthood. 
In Swedish studies of hospital-born infants, pre-eclampsia was
found to have a ‘protective’ effect on breast cancer risk (Ekbom et
al, 1992, 1997). In the present study, no marked effect on cancer
risk was found with maternal proteinuria, which may be too crude
a measure of pre-eclampsia, maternal blood pressure at delivery
not being recorded. On the other hand, maternal proteinuria was
highly negatively associated with weight at birth (data not shown)
in the current study. Low weight at birth, a possible consequence
of maternal pre-eclampsia, may be the determining factor in the
relation rather than the pre-eclampsia per se. 
Age at menarche may be an explanatory factor for hormone-
related cancer risk and size at birth but was available for only a
portion of our sample; it cannot be excluded as a possible impor-
tant covariate (Hsieh et al, 1990). 
If size at birth is a risk factor for later disease, what factors predis-
pose for large size? Larger size at birth may be a consequence of
hyperinsulinism due to impaired maternal glucose tolerance or
gestational diabetes (D’Ercole, 1999). In this study maternal
glucose measurements were not routinely made during the study
period. In our own review of hospital births for this period
(1914–1930), no mother was recorded as diabetic before or during
the period of pregnancy and women with diabetes were most prob-
ably advised against pregnancy at that time period, if they indeed
survived into adulthood with childhood diabetes. Large size at
birth generally reflects genetic propensity based on maternal and
paternal genotype rather than pathological overgrowth (D’Ercole,
1999). It cannot be excluded that an as  yet unknown growth
factor-X may lead to increased fetal growth and/or increased risk
for cancer. Insulin-like growth factor II (IGF-II) plays a funda-
mental role in human fetal growth and has been implicated to be
involved in human tumorigenesis (O’Dell and Day, 1998). Growth
factors at birth were not assessed in our study. 
Lack of statistical significance may be attributed to low power
due to the small number of cases when looking at individual or
limited groupings of cancer sites in this study. Despite lack of
significance in some of the modelling, there are strong suggestions
of an increase in cancer risk with higher birth weight and birth
length. 
At the population study onset, the participation rate was
90.6% (Bengtsson et al, 1973), and all women identified in the
Table 5 Cancer risk by tertilea birth length (n = 872 women) 
Rate ratio 
(95% confidence limits) 
T2 T3 P for trend 
All sitesb (cases = 198) 1.13 (0.76, 1.69) 1.57 (1.12, 2.21) 0.0071 
c+ maternal proteinuria 1.16 (0.77, 1.75)  1.57 (1.11, 2.24) 0.0090 
+ birth order 1.13 (0.75, 1.69) 1.54 (1.09, 2.18) 0.0110 
+ own parity 1.14 (0.76, 1.70) 1.56 (1.11, 2.19) 0.0082 
+ age at menarched 1.00 (0.63, 1.58) 1.54 (1.06, 2.25) 0.0178 
Hormonalb,e (cases = 74) 1.06 (0.56, 2.02)  1.35 (0.78, 2.33) 0.272 
c+ maternal proteinuria 1.02 (0.53, 1.97)  1.33 (0.76, 2.34) 0.293 
+ birth order 1.06 (0.56, 2.02) 1.33 (0.77, 2.32) 0.295 
+ own parity 1.07 (0.56, 2.04) 1.35 (0.78, 2.34) 0.271 
+ age at menarched 1.07 (0.50, 2.30) 1.62 (0.86, 3.06) 0.119 
Breastb (cases = 43) 1.41 (0.61, 3.25)  1.48 (0.70, 3.16) 0.330 
c+ maternal proteinuria 1.36 (0.57, 3.27)  1.48 (0.67, 3.26) 0.343 
+ birth order 1.41 (0.61, 3.25) 1.43 (0.66, 3.06) 0.392 
+ own parity 1.41 (0.61, 3.26) 1.48 (0.70, 3.16) 0.327 
+ age at menarched 1.58 (0.56, 4.49) 2.21 (0.88, 5.53) 0.087 
Non-hormonalb,f (cases = 124) 1.17 (0.70, 1.97) 1.72 (1.12, 2.66) 0.0107 
c+ maternal proteinuria 1.26 (0.75, 2.14)  1.75 (1.11, 2.74) 0.0129 
+ birth order 1.17 (0.70, 1.97) 1.68 (1.09, 2.61) 0.0163 
+ own parity 1.17 (0.70, 1.97) 1.70 (1.10, 2.63) 0.0130 
+ age at menarched 0.96 (0.54, 1.71) 1.50 (0.94, 2.41) 0.0712 
Digestive systemb (cases = 36) 0.83 (0.30, 2.30) 1.65 (0.76, 3.58) 0.169 
c+ maternal proteinuria 0.88 (0.30, 2.30)  1.56 (0.76, 3.58) 0.178 
+ birth order 0.83 (0.30, 2.27) 1.49 (0.68, 3.27) 0.279 
+ own parity 0.85 (0.31, 2.32) 1.66 (0.77, 3.60) 0.165 
+ age at menarched 0.45 (0.12, 1.65) 1.43 (0.62, 3.30) 0.335 
Hormonal + colonb (cases = 93) 1.02 (0.56, 1.85) 1.57 (0.96, 2.56) 0.0581 
c+ maternal proteinuria 1.00 (0.54, 1.86)  1.54 (0.93, 2.56) 0.0743 
+birth order 1.02 (0.56, 1.85) 1.55 (0.94, 2.54) 0.0687 
+ own parity 1.03 (0.57, 1.86) 1.57 (0.96, 2.57) 0.0568 
+ age at menarched 0.97 (0.48, 1.98) 1.80 (1.02, 3.17) 0.0296 
a Where tertile 1 (T1) is reference bAdjusted for cohort membership and gestational age. cFurther adjusted for listed factor. dAge at
menarche available for only 752 women. eWhere hormonal = breast, uterine and ovarian cancers and fnon-hormonal = all other
sites. 1198 SW Andersson et al 
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complementary population could be followed from birth to
endpoint by tracing parish records throughout the lifespan.
Original birth records could be traced for 68% of the women in the
study population. Access to original midwife records and parish
records has the advantage of eliminating recall bias and misclassi-
fication since we do not rely upon self-reported birth data
(Andersson et al, 2000a). An earlier study in the same population
material found the Swedish Cancer Registry database to have
captured 99% of cancer cases (Helgesson et al, 1994) attesting to
completeness of the cancer endpoint. Aside from age at menarche
which was attained by questionnaire, all variables were extracted
from original records. 
The present findings can be seen from 2 viewpoints: (a) there is
a higher risk for cancer with higher birth weight or, (b) there is a
protective effect of low birth weight on cancer risk independent of
gestational age. In either case, the balance of evidence suggests
that size at birth may require consideration in the pathogenesis of
adult cancers. Our findings warrant further study in larger data sets. 
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